Product Information
CIALIS 5 MG TABLET is a brand product labeled by Eli Lilly and Company, priced at $9.2045 per EA under NDC 00002446230. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 21, 2003. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Tadalafil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Eli Lilly and CompanyNDC
00002446230
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TADALAFILApproval Type
New Drug (NDA)
FDA Application
NDA021368FDA Approved
11/21/2003
TE Code
AB1
On Market Since
11/26/2003
Pharmacological Classes
Price Statistics
The NADAC for CIALIS 5 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 107.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2045 per EA |
|---|---|
| All-time high | $11.3941 (Jul 14, 2021) |
| All-time low | $4.4371 (Nov 28, 2013) |
| 52-week high | $9.2394 |
| 52-week low | $9.2045 |
| Median price | $9.9328 |
| Average price | $9.6064 |
| Largest weekly change | +20.0% (Dec 25, 2013) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eli Lilly and Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tadalafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIALIS 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CIALIS 5 MG TABLET, manufactured by Eli Lilly and Company, is $9.2045 per EA (NDC 00002446230), effective Sep 30, 2026.
How has the price of CIALIS 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CIALIS 5 MG TABLET has risen 107.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIALIS 5 MG TABLET?
Since Nov 28, 2013, the NADAC for CIALIS 5 MG TABLET has ranged from a low of $4.4371 (Nov 28, 2013) to a high of $11.3941 (Jul 14, 2021), with a median of $9.9328 per EA.
Are there cheaper alternatives to CIALIS 5 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 5 MG TABLET, is $0.1032 per EA — about 99% below CIALIS 5 MG TABLET.
Who manufactures CIALIS 5 MG TABLET?
CIALIS 5 MG TABLET (NDC 00002446230) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.